Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gray

Showing results (1441-1450 of 1,482) with videos related to

Pageof 149
Sort By:
Journal of the American College of Cardiology|February 7, 2018
<sup>18</sup>F-Sodium Fluoride Uptake in Abdominal Aortic Aneurysms: The SoFIA<sup>3</sup> StudyRachael O Forsythe, Marc R Dweck, Olivia M B McBride, et al.
JCI Insight|February 8, 2022
Immunoglobulin A nephropathy is characterized by anticommensal humoral immune responsesElissa G Currie, Bryan Coburn, Elisa A Porfilio, et al.
Science (New York, N.Y.)|July 6, 2019
The heme-regulated inhibitor is a cytosolic sensor of protein misfolding that controls innate immune signalingMena Abdel-Nour, Leticia A M Carneiro, Jeffrey Downey, et al.
Vaccine|April 20, 2007
Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of ResearchMark E Polhemus, Alan J Magill, James F Cummings, et al.
Malaria Journal|January 25, 2013
Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01Nekoye Otsyula, Evelina Angov, Elke Bergmann-Leitner, et al.
Plos One|March 6, 2009
Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western KenyaBernhards R Ogutu, Odika J Apollo, Denise McKinney, et al.
Nature Medicine|November 21, 2018
Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphomaRishu Agarwal, Yih-Chih Chan, Constantine S Tam, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 9, 2019
Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's diseaseSuzanne E Schindler, Yan Li, Kaitlin W Todd, et al.
Blood|October 29, 2024
Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemiaMeng-Xiao Luo, Tania Tan, Marie Trussart, et al.
Heliyon|January 4, 2023
Survival-based CRISPR genetic screens across a panel of permissive cell lines identify common and cell-specific SARS-CoV-2 host factorsKatherine Chan, Adrian Granda Farias, Hunsang Lee, et al.
Pageof 149

Showing results (1441-1450 of 1,482) with videos related to

Sort By:
Pageof 149
Journal of the American College of Cardiology|February 7, 2018
<sup>18</sup>F-Sodium Fluoride Uptake in Abdominal Aortic Aneurysms: The SoFIA<sup>3</sup> StudyRachael O Forsythe, Marc R Dweck, Olivia M B McBride, et al.
JCI Insight|February 8, 2022
Immunoglobulin A nephropathy is characterized by anticommensal humoral immune responsesElissa G Currie, Bryan Coburn, Elisa A Porfilio, et al.
Science (New York, N.Y.)|July 6, 2019
The heme-regulated inhibitor is a cytosolic sensor of protein misfolding that controls innate immune signalingMena Abdel-Nour, Leticia A M Carneiro, Jeffrey Downey, et al.
Vaccine|April 20, 2007
Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of ResearchMark E Polhemus, Alan J Magill, James F Cummings, et al.
Malaria Journal|January 25, 2013
Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01Nekoye Otsyula, Evelina Angov, Elke Bergmann-Leitner, et al.
Plos One|March 6, 2009
Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western KenyaBernhards R Ogutu, Odika J Apollo, Denise McKinney, et al.
Nature Medicine|November 21, 2018
Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphomaRishu Agarwal, Yih-Chih Chan, Constantine S Tam, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 9, 2019
Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's diseaseSuzanne E Schindler, Yan Li, Kaitlin W Todd, et al.
Blood|October 29, 2024
Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemiaMeng-Xiao Luo, Tania Tan, Marie Trussart, et al.
Heliyon|January 4, 2023
Survival-based CRISPR genetic screens across a panel of permissive cell lines identify common and cell-specific SARS-CoV-2 host factorsKatherine Chan, Adrian Granda Farias, Hunsang Lee, et al.
Pageof 149